Stock UniverseDerived research view · source repositories remain read-only

Esperion Therapeutics, Inc. (ESPR)

Therapeutics / Biopharma · Healthcare / Drug Manufacturers - Specialty & Generic
Score Band
Speculative
Selection Score
25.32
Global Rank
2753
Market Cap
788.69M
Latest Close
3.13
RS Composite
-7.55% · G#1931

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-0.63%
3M
15.07%
6M
-17.20%
1Y
179.46%
3Y
130.15%
5Y
-84.28%
10Y
-81.72%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 8.28M · 30-day average: 17.71M · Max drawdown over stored range: -99.10%

Research Snapshot

Relative Strength vs SPX

RS Composite-7.55%
20D RS-0.95%
60D RS11.88%
120D RS-30.28%
Global RS Rank1931 · 42.44% percentile
Watch+Speculative RS Rank1216 · 42.01% percentile
Group ScopeWatch+Speculative
Primary RS Rank188 · 58.95% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank346 / 701
Primary Percentile50.78
Score Notesmarket-cap support, industry-tailwind, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for ESPR.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue227.54778.44775.475116.334332.314403.135
Revenue Growth (YoY)53.371%-65.525%-3.789%54.136%185.655%21.311%
Gross Profit78.219-41.745-70.419-13.04217.475
Operating Income-121.396-213.48-179.501-155.56354.402
Free Cash Flow-86.046-263.809-174.827-135.487-23.971-13.093
Free Cash Flow Per Share-3.132-9.128-2.633-1.314-0.128-0.0629879727754176
EPS (Diluted) GAAP-5.225-9.310887-3.518577-2.029433-0.276442
EPS Growth
EPS Non-GAAP
Gross Margin34.375%-53.214%-93.301%-11.209%65.443%67.9452%
Operating Margin-53.35%-272.133%-237.828%-133.721%16.371%14.9511%
Profit Margin-63.086%-343.044%-309.585%-179.868%-15.571%-5.6264%
Free Cash Flow Margin-37.815%-336.289%-231.636%-116.464%-7.213%-3.2478%
Shares Outstanding (Diluted)27.473928.902566.4072103.1066187.1819207.8651
Shares Change (YoY)1.416%5.2%129.763%55.264%81.542%11.05%

SEC Quarterly Fundamentals

No processed quarterly rows for ESPR.